Mindfulness-Based Cognitive Therapy (MBCT)
Mindfulness-Based Cognitive Therapy (MBCT) is a cognitive-behavioral relapse-prevention program developed by Zindel Segal, Mark Williams and John Teasdale, published in 2002. Its core mechanism: mindful awareness of depressive cognitive patterns enables decentering and prevents ruminative relapse spirals. This catalogue links it to depression and insomnia, typically in group format, short (8-week).
Related condition topics
These links support exploration. They do not establish that MBCT is effective or recommended for each condition.
How Mindfulness-Based Cognitive Therapy works
Mindful awareness of depressive cognitive patterns enables decentering and prevents ruminative relapse spirals
Ontology
Depressive relapse maintained by reactivation of ruminative cognitive patterns triggered by low mood
Therapeutic Voice
"Notice the thought arriving, not as truth, but as a mental event. Thoughts are not facts."
View of the Person
A ruminative mind that can learn to observe its own patterns without being captured by them
Epistemology
Evidence
1 condition assessment available
An overall effectiveness assessment has not been completed. Completed assessments for specific populations appear below.
Condition-specific assessments
Each conclusion applies to the population and use described. These source-based assessments do not certify the full entry or replace expert clinical review.
Depression & Mood Disorders
Population and scope: Adults with uncomplicated MDD, or remitted MDD with high relapse risk.
Guideline recommendation
VA/DoD 2022 weakly includes MBCT for initial psychotherapy selection (recommendation 7) and separately for continuation after remission in patients at high relapse risk (22). Neither recommendation establishes superiority; acute treatment and relapse prevention are distinct scopes.
Source assessment dated
Guidelines and official sources (14)
13 clinical guideline checks · 1 evidence registry check
Read the recommendation and its scope. A source may discuss an approach without recommending it.
- Depression in adults: treatment and management (NG222)
Recommendation for the stated population
NICE lists group MBCT as a relapse-prevention option, with or without continuing antidepressants according to preference.
Scope: People remitted on antidepressants alone and at higher relapse risk
- Mindfulness-based cognitive therapy
Discussed in the source
The archive lists Strong under 1998 criteria and pending 2015 re-evaluation.
Scope: MBCT; depression/relapse prevention evidence
- Depression in adults: treatment and management (NG222)
Recommendation for the stated population
NICE includes group mindfulness and meditation using a programme such as MBCT among treatment options. This is separate from its relapse-prevention recommendations.
Scope: Adults with a new episode of less severe depression; depression-specific group programme.
- Clinical Practice Guideline for Management of PTSD and Acute Stress Disorder
Insufficient evidence for or against
VA/DoD finds insufficient evidence for or against MBCT for PTSD.
Scope: Adults with PTSD; mind-body interventions.
- Management of Major Depressive Disorder
Recommendation for the stated population
VA/DoD suggests mindfulness-based cognitive therapy among seven unranked psychotherapy options (weak for). Treatment strategy also depends on severity, chronicity, prior response and preference.
Scope: Adults with uncomplicated MDD choosing psychotherapy.
- Management of Major Depressive Disorder
Discussed in the source
VA/DoD strongly recommends first-line evidence-based psychotherapy, referring to the list that includes mindfulness-based cognitive therapy. This is a class-level recommendation, with no preferred individual approach.
Scope: Pregnant or breastfeeding adults with mild-to-moderate MDD.
- Management of Major Depressive Disorder
Recommendation for the stated population
VA/DoD suggests MBCT during continuation treatment to reduce relapse or recurrence (weak for). CBT, IPT and MBCT are not ranked against one another.
Scope: Remitted MDD with high risk of relapse or recurrence.
- Clinical Practice Guideline for the Management of Chronic Multisymptom Illness
Discussed in the source
The guideline discusses an IBS adaptation of MBCT within a weak recommendation for mindfulness-based therapies. This is not a separate recommendation for standard MBCT across all chronic multisymptom illnesses.
Scope: MBCT adapted for IBS within the chronic multisymptom illness guideline.
- Management of Headache
Discussed in the source
The recommendation is neutral for the mindfulness-based therapy category; the discussion includes MBCT. It does not assign MBCT a separate recommendation grade.
Scope: Mindfulness-based interventions for headache treatment or prevention.
- Tinnitus
Discussed in the source
The guideline is neutral for mindfulness-based therapies. MBCT appears in the evidence discussion, without a separate MBCT recommendation grade.
Scope: Mindfulness-based therapies for adults with bothersome tinnitus.
- Management of Type 2 Diabetes Mellitus
Discussed in the source
The review includes MBCT within mindfulness/acceptance interventions. The graded recommendation concerns a stress-reduction programme category, without a separate MBCT grade or established long-term benefit.
Scope: Adults with stress related to type 2 diabetes.
- Clinical Practice Guideline for Management of Stroke Rehabilitation
Discussed in the source
VA/DoD weakly recommends mindfulness-based therapies and specifically reviews MBSR and MBCT. The recommendation is for the therapy family in this post-stroke population.
Scope: Depression following stroke.
- Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts
Discussed in the source
APA includes MBCT among broadly comparable models; it cannot recommend a superior monotherapy.
Scope: Adults with depressive disorders, excluding psychotic depression; initial monotherapy selection.
- Clinical Practice Guideline for Tobacco Use Treatment
Discussed in the source
VA/DoD weakly recommends against standalone mindfulness for this cessation goal. This is category-level guidance; MBCT is not separately graded, and the statement does not address adjunctive use or other conditions.
Scope: Mindfulness used as a standalone treatment for abstinence from tobacco or nicotine.
Recorded material under review
The existing notes below are retained separately from assessment records. These recorded claims await source checking, including study design, recommendations and numerical estimates.
10+ RCTs
Kuyken et al. (2016) IPD meta-analysis
Very strong evidence for preventing relapse (3+ episodes). Comparable to maintenance antidepressants.
Training and certification
Licensed clinician with CBT competency. Personal mindfulness practice (1+ year daily practice) and MBCT participation as prerequisite. Training through Oxford Mindfulness Centre, UC San Diego, or equivalent.
Oxford Mindfulness Centre, UC San Diego, and other recognized programs offer teacher training and certification pathways.
6–12 months formal teacher training; prerequisite: 1+ year personal mindfulness practice + MBCT group participation
$3K–8K for teacher training; retreat costs additional
Clinical cautions and blind spots
Assessment and precautions
Acute depressive episode (designed for remission, not acute phase), active suicidality, active psychosis, severe dissociation where mindfulness may trigger depersonalization, acute trauma
Blind spots
Primarily relapse prevention: not first-line for acute depression; requires meditation capacity some clients lack
Philosophical roots
Buddhist psychology (mindfulness, non-attachment to thoughts); Husserl (epoché: suspending natural attitude); Kabat-Zinn (secularized dharma); Teasdale (interacting cognitive subsystems)
Compared with other approaches
Test Yourself
How does MBCT prevent relapse?
Show answer
Recognizing early warning signs; relating to thoughts as mental events rather than entering ruminative spirals.